Large clinicals trials evaluating TNF-α inhibitors in HF (Randomised Etanercept Worldwide Evaluation (RENEWAL) [35], Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) [36]) have yielded dissatisfactory results and further testing of TNF-α inhibitors in patients seems currently unlikely. The gene discussed is TNF; the disease is congestive heart failure.